Sclerodermiform linear atrophy after the use of intralesional steroids for periorbital hemangiomas: a review of complications.
A 1-year-old girl developed a linear atrophy 3 months after a second injection of intralesional steroids for a periorbital hemangioma, followed by spontaneous resolution of the atrophy within 13 months. Reported and potential complications of intralesional steroids for periorbital hemangiomas are reviewed.
Vazquez-Botet
R
R
Department of Ophthalmology, University of Puerto Rico, School of Medicine, San Juan 00936.
Reyes
B A
BA
Vazquez-Botet
M
M
D001284:Atrophy / Q000150:complications; D003907:Dexamethasone / Q000009:adverse effects*; D005142:Eyelid Neoplasms / Q000188:drug therapy*; D005143:Eyelids / Q000473:pathology; D005260:Female; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007267:Injections; D012595:Scleroderma, Systemic / Q000139:chemically induced* / Q000150:complications; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014792:Visual Acuity
D003907:Dexamethasone; D014222:Triamcinolone Acetonide